Myocardial hypertrophy, angiotensin, and ACE inhibitors.

about

Complementation of reduced survival, hypotension, and renal abnormalities in angiotensinogen-deficient mice by the human renin and human angiotensinogen genes.The natural history of left ventricular wall thickening in hypertrophic cardiomyopathy.

P2860

Q37365115-8173149A-7851-4BB6-9BC3-08F6A6D9C957 Q50966008-12876701-5788-46EB-86BF-8C6A7B4FC405

P2860

Myocardial hypertrophy, angiotensin, and ACE inhibitors.

Item

http://www.wikidata.org/entity/Q40779473

description

1993 nî lūn-bûn

@nan

1993年の論文

@ja

1993年学术文章

@wuu

1993年学术文章

@zh-cn

1993年学术文章

@zh-hans

1993年学术文章

@zh-my

1993年学术文章

@zh-sg

1993年學術文章

@yue

1993年學術文章

@zh

1993年學術文章

@zh-hant

name

Myocardial hypertrophy, angiotensin, and ACE inhibitors.

@en

type

Item

label

Myocardial hypertrophy, angiotensin, and ACE inhibitors.

@en

prefLabel

Myocardial hypertrophy, angiotensin, and ACE inhibitors.

@en

P1476

Myocardial hypertrophy, angiotensin, and ACE inhibitors.

@en

P2093

R N Re

http://www.w3.org/2001/XMLSchema#string

P2860

The mas oncogene encodes an angiotensin receptor

Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells.

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation

Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat.

Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure.

Significance of the vascular renin-angiotensin pathway.

Endogenous tissue renin-angiotensin systems. From molecular biology to therapy.

Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension.

P304

875-881

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/000331979304401105

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1993-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8239059

http://www.w3.org/2001/XMLSchema#string

Myocardial hypertrophy, angiotensin, and ACE inhibitors.

about

P2860

P2860

Myocardial hypertrophy, angiotensin, and ACE inhibitors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698